Clinical trials
Phase 4 Pruritus trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 2 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Terminated | 4 |
| Recruiting | 2 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mahidol University | 2 |
| Novartis Pharmaceuticals | 2 |
| Ankara University | 1 |
| Assiut University | 1 |
| Can Tho University of Medicine and Pharmacy | 1 |
| Casa Espirita Terra de Ismael | 1 |
| Ceragenix Pharmaceuticals | 1 |
| Charite University, Berlin, Germany | 1 |
| China Medical University Hospital | 1 |
| Columbia University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pruritus | 33 |
| Dermatitis, Atopic | 7 |
| Nausea | 6 |
| Vomiting | 5 |
| Postoperative Pain | 4 |
| Eczema | 3 |
| Plaque, Amyloid | 2 |
| Postoperative Nausea and Vomiting | 2 |
| Psoriasis | 2 |
| Uremia | 2 |
Trials
Showing 76 to 33 of 33. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.